Back

CHA2DS2-VASc vs. CHA2DS2-VA regarding their stroke risk stratifications in patients with atrial fibrillation: insights from the GLORIA-AF registry

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Stroke prediction in atrial fibrillation Stroke Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Steven Ho Man Lam

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on stroke prevention in atrial fibrillation
Professor E. Hylek (Boston, US)
Slides Video
Presentation thumbnail
Cancer as independent risk factor for ischemic stroke in low-risk patients with atrial fibrillation: Swedish national cohort study
Doctor A. Karagianni (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Is the risk of ischemic stroke lower in atrial flutter compared to atrial fibrillation?
Doctor H. Eyob Fesseha (Helsinki, FI) Doctor M. Lehto (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Leveraging deep learning for detecting atrial fibrillation and flutter and predicting thromboembolic events from images of 12-lead electrocardiograms in sinus rhythm
Doctor A. Aminorroaya (New Haven, US)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke prediction in atrial fibrillation
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The new CHA2DS2-VA score: is female sex still a risk factor or not?
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources